From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

Learn more about whether Alvotech or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In an era of rapid digital transformation, the pharmaceutical industry is increasingly leveraging advanced integration technologies to streamline operations and enhance efficiency. Rishi Nareshbhai ...

Interview with the Chairman and CEO: MAIA Biotechnology Inc. (NYSEAMERICAN:MAIA) Vlad Vitoc Interview with the Chairman and CEO: Mira Pharmaceuticals, Inc. (NASDAQ:MIRA) and Telomir ...

The Korea Biotechnology Industry Organization (KBIO) said Wednesday it has requested the United States to exempt South Korea ...

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell this week. The stock lost 24% as of market close on Friday. The move ...

The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...

The Pharma AI Council officially launched today, establishing a new force to drive innovation and the responsible application ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.